Literature DB >> 31551418

Longitudinal RNA-Seq analysis of acute and chronic neurogenic skeletal muscle atrophy.

Jeffrey T Ehmsen1, Riki Kawaguchi2,3, Ruifa Mi1, Giovanni Coppola2,3, Ahmet Höke4.   

Abstract

Skeletal muscle is a highly adaptable tissue capable of changes in size, contractility, and metabolism according to functional demands. Atrophy is a decline in mass and strength caused by pathologic loss of myofibrillar proteins, and can result from disuse, aging, or denervation caused by injury or peripheral nerve disorders. We provide a high-quality longitudinal RNA-Seq dataset of skeletal muscle from a cohort of adult C57BL/6J male mice subjected to tibial nerve denervation for 0 (baseline), 1, 3, 7, 14, 30, or 90 days. Using an unbiased genomics approach to identify gene expression changes across the entire longitudinal course of muscle atrophy affords the opportunity to (1) establish acute responses to denervation, (2) detect pathways that mediate rapid loss of muscle mass within the first week after denervation, and (3) capture the molecular phenotype of chronically atrophied muscle at a stage when it is largely resistant to recovery.

Entities:  

Mesh:

Year:  2019        PMID: 31551418      PMCID: PMC6760191          DOI: 10.1038/s41597-019-0185-4

Source DB:  PubMed          Journal:  Sci Data        ISSN: 2052-4463            Impact factor:   6.444


Background & Summary

Skeletal muscle atrophy is the loss of muscle mass and function that occurs in response to diverse stimuli including disuse/immobility, glucocorticoid treatment, cancer, aging, and denervation[1-5]. Biologically, atrophy reflects the active loss of skeletal muscle contractile proteins, leading to loss of strength and functional impairment with substantial impact on quality of life and, in some cases, reduced survival[6-8]. In addition, chronically denervated, atrophied muscle shows impaired capacity for reinnervation and functional recovery, which significantly limits prospects for recovery in settings of chronic neuromuscular disease, delayed repair, or large nerve lesions[9-12]. Nerve-evoked contraction is the most important factor for maintaining or regaining muscle mass and force[13]. Neurogenic atrophy refers specifically to skeletal muscle atrophy resulting from denervation, as may occur in traumatic injury or diseases that affect the peripheral nervous system, such as amyotrophic lateral sclerosis (ALS)[14-17]. A number of “atrogenes” are induced as a result of denervation and in response to various triggers of muscle atrophy; among these are specific ubiquitin ligases targeting components of the sarcomere[18-29]. A comprehensive analysis of the global gene pathways that change in response to denervation and during atrophy may offer an optimal chance of identifying means to pharmacologically maintain or increase muscle mass and function in atrophy-associated disease states. We provide here a comprehensive RNA-Seq dataset[30] to identify gene expression changes across the entire longitudinal course of muscle atrophy, affording the opportunity to (1) establish acute responses to denervation within the first day, (2) detect pathways that mediate rapid proteolysis and loss of muscle mass within the first week after denervation, and (3) capture the molecular phenotype of chronically atrophied muscle (weeks to months after denervation) at a stage when it is largely resistant to reinnervation and recovery. We generated a longitudinal RNA-Seq dataset from a cohort of adult (8-week-old) wild type C57BL/6 J male mice denervated for 0 (baseline), 1, 3, 7, 14, 30, or 90 days (n = 4 for each timepoint)[30]. We elected to use tibial nerve transection as a model for muscle denervation, as this approach is physiologically meaningful while limiting the morbidity (i.e., pain and immobility) associated with complete sciatic nerve transection[31]. The tibial nerve is the largest branch of the sciatic nerve that supplies skeletal muscles of the posterior compartment of the lower limb, including the gastrocnemius and soleus. In brief, we identified and separated the tibial nerve from other branches of the sciatic nerve, then ligated, cut distally, and sutured the proximal stump in place to prevent muscle reinnervation during chronic studies. We have established that this model reliably induces significant gastrocnemius atrophy within one week after denervation, with atrophy becoming progressively more severe over time (Fig. 1c,d).
Fig. 1

Overview of the experimental procedure. The tibial nerve, the largest branch of the sciatic nerve, supplies the gastrocnemius muscle and other muscles of the lower limb posterior compartment. In our mouse model of denervation atrophy, the sciatic nerve is identified, and its branches separated to isolate the tibial nerve (a; nerve identities are as follows: 1, sural nerve; 2, tibial nerve; 3, common peroneal/fibular nerve; 4, sciatic nerve). We generated a cohort of C57BL/6 J male mice denervated for 0, 1, 3, 7, 14, 30, or 90 days (b,c). Significant atrophy is apparent by 7 days after denervation, with consistent decline in mass during chronic denervation (d); ***P < 0.001 compared to baseline.

Overview of the experimental procedure. The tibial nerve, the largest branch of the sciatic nerve, supplies the gastrocnemius muscle and other muscles of the lower limb posterior compartment. In our mouse model of denervation atrophy, the sciatic nerve is identified, and its branches separated to isolate the tibial nerve (a; nerve identities are as follows: 1, sural nerve; 2, tibial nerve; 3, common peroneal/fibular nerve; 4, sciatic nerve). We generated a cohort of C57BL/6 J male mice denervated for 0, 1, 3, 7, 14, 30, or 90 days (b,c). Significant atrophy is apparent by 7 days after denervation, with consistent decline in mass during chronic denervation (d); ***P < 0.001 compared to baseline. The samples collected and described in this manuscript include transcriptional profiles from a total of 28 denervated gastrocnemii and 28 contralateral (paired) intact gastrocnemii, comprising 4 denervated and 4 contralateral (paired) intact gastrocnemii for each of 7 denervation durations [0 (baseline), 1, 3, 7, 14, 30, and 90 days][30]. All specimens were generated from a cohort of male C57BL/6 J mice that were 8 weeks of age at the start of the study. These data provide a comprehensive description of baseline gene expression in adult mouse skeletal muscle and a broad assessment of the acute and longitudinal gene expression changes in atrophying muscle associated with denervation.

Methods

Animal husbandry

8-week-old C57BL/6 J male mice (Stock #000664) were obtained from the Jackson Laboratory (Bar Harbor, ME) and randomized into 7 groups of n = 4 mice per group for the following denervation timepoints: 0, 1, 3, 7, 14, 30, and 90 days. Animal subjects were housed in a controlled environment with a 12:12-h light-dark cycle with ad libitum access to water and food (Envigo 2018 SX). All mouse experiments were carried out under protocols approved by the JHU Animal Care and Use Committee.

Tibial nerve denervation surgery

Mice were anesthetized with 1.5% isoflurane/2% oxygen using a VetEquip inhalation system (Livermore, CA). The left hindlimb was shaved and sterilized, and a 1 cm incision was introduced in the skin overlying the dorsal thigh. Myofascial planes were gently separated to reveal the sciatic nerve. The tibial nerve branch was identified at its distal branch point and gently separated from the sciatic and peroneal nerves, then ligated proximally and distally using a 10-0 polyamide monofilament suture. The tibial nerve was then transected, the nerve length between ligatures carefully resected, and the proximal stump sutured to the biceps femoris muscle to prevent distal reinnervation. The incision was then closed using stainless steel wound clips. Mice were monitored for recovery from anesthesia and then returned to their home cages.

Myofiber morphometry

Gastrocnemii were frozen in O.C.T. in liquid nitrogen-cooled isopentane, then sectioned at 10 μm. Mid-belly transverse sections were blocked with M.O.M. in PBS (1:40 dilution, Vector Laboratories, catalogue #MKB-2213) at room temperature for 1 h, then incubated overnight at 4 °C with a mixture of BA-D5 supernatant (1:100, myosin heavy chain type I, SC-71 supernatant (1:100, myosin heavy chain type IIa), BF-F3 concentrate (1:100, myosin heavy chain type IIb) [all from the Developmental Studies Hybridoma Bank (DSHB)], and rat-anti-laminin (1:1000, Sigma, catalogue #L0663) in 1% BSA/PBS. Sections were then washed 3 × 5 min in PBS and incubated with a mixture of the following secondary antibodies (all at 1:500) for 2 h at room temperature: goat-anti-mouse IgG2b-DyLight-405, IgG1-Alexa Fluor-488, IgM-Alexa Fluor-594 (all from Jackson ImmunoResearch, catalogue numbers 115-475-207, 115-545-205, and 115-585-075, respectively), and goat anti-rat-IgG-Alexa Fluor-647 (Thermo Fisher Scientific, catalogue #A-21247), diluted in 1% BSA/PBS. Sections were washed 3 × 5 min in PBS and coverslipped using Prolong Gold antifade (Thermo Fisher Scientific, catalogue #P36930). Transverse sections were imaged in their entirety using a Zeiss AxioObserver. Myofiber minimum Feret diameters were determined using Fiji (NIH)[32], with ~100 randomly selected myofibers of each fiber type (type I, II, or IIa) measured from each of 3 biological replicates for each indicated timepoint. Statistical analysis was performed using Stata v. 11.2 (College Station, TX)[33].

RNA Isolation

Skeletal muscle was homogenized in TRIzol (Ambion, catalogue #15596018) using RNase-free stainless steel beads (Next Advance, catalogue #SSB02-RNA). Homogenates were centrifuged at 10,000 rpm at 4 °C for 10 min to pellet debris, and RNA was purified from the TRIzol supernatant using a Direct-Zol RNA mini purification kit with on-column DNase digestion (Zymo Research, catalogue #R2072). RNA integrity (RIN) was assayed using an Agilent 2100 Bioanalyzer.

RNA-Seq library preparation, sequencing, and bioinformatics analysis

RNA-sequencing was carried out using TrueSeq RiboZero gold (stranded) kit (Illumina, catalogue #20020597). Libraries were indexed and sequenced over 18 lanes using HiSeq4000 (Illumina) with 69-bp paired end reads. Quality control (QC) was performed on base qualities and nucleotide composition of sequences using FastQC version 0.11.5[34], to identify problems in library preparation or sequencing. Sequence quality for the dataset described here was sufficient that no reads were trimmed or filtered before input to the alignment stage. Paired-end reads were aligned to the most recent Mus musculus mm10 reference genome (GRCm38.75) using the STAR spliced read aligner (version 2.4.0)[35]. Average input read counts were 58.0 M per sample (range 39.1 M to 91.0 M) and average percentage of uniquely aligned reads was 81.9% (range 72.3% to 88.6%). Total counts of read-fragments aligned to known gene regions within the mouse (mm10) refSeq (refFlat version 07.24.14) reference annotation were used as the basis for quantification of gene expression. Fragment counts were derived using HTSeq (version 0.6.0) and the mm10 refSeq transcript model[36]. Low count transcripts were filtered, and count data were normalized using the method of trimmed mean of M-values (TMM)[37] followed by removing unwanted variation using Bioconductor package RUVseq[38] with k value of 1. Differentially expressed genes (FDR < 0.1) were then identified using the Bioconductor package limma with voom function to estimate mean-variance relationship, followed by empirical Bayes moderation[39-41]. Pairwise comparisons between denervated and contralateral intact muscle at each timepoint were used as the basis for model contrasts. All bioinformatics analyses were conducted using R version 3.5.1[42].

Data Records

Sequencing data in the fastq format have been deposited in NCBI Sequence Read Archive (SRA)[30]. A metadata table (Supplementary Table S1) is available with details for each sample.

Technical Validation

Reproducible skeletal muscle atrophy using tibial nerve denervation model

Tibial nerve denervation resulted in a reliable time-dependent loss of skeletal muscle mass, with a significant difference in mass between denervated and contralateral intact gastrocnemii detected by day 7 post-denervation (Fig. 1c,d). All mice used in this study entered the cohort at the same time, with sequential denervation according to the designated timepoints, to remove age as a potential confounding variable. Mouse gastrocnemius contains a mixed population of myofiber types including so-called slow twitch myofibers (type I) and fast twitch myofibers (type IIa and IIb). After muscle denervation, all three of these myofiber populations showed a significant reduction in size as measured by minimum Feret diameter, with the most substantial rate of individual myofiber atrophy occurring within the first two weeks post-denervation (Fig. 2). Type IIb myofibers, the most abundant myofiber type in mouse gastrocnemius, showed the largest magnitude of atrophy (Fig. 2f). Multiple linear regression with myofiber type, myofiber type-time interactions, and time modeled with a spline at t = 14 days was used to model rates of atrophy among type I, IIa, and IIb myofibers; bootstrapping was used to estimate standard errors. Results are presented in Table 1.
Fig. 2

Gastrocnemius myofiber morphometry. Atrophy of type I, IIa, and IIb myofibers was analyzed by assessment of minimum Feret diameter at baseline (t = 0 days) and 7, 14, 30, and 72 days post-denervation. All three myofiber types showed significant atrophy within the first week after denervation, with the greatest change in magnitude observed for type IIb myofibers overall. Scale bar, 100 μm.

Table 1

Myofiber type-dependent atrophy during acute and chronic denervation.

0–14 days denervationΔ minimum Feret diameter (μm/day)standard error (μm/day)95% CIP (compared to type IIb)
type IIb−3.030.07−3.16, −2.89
  IIa−0.800.04−0.90, −0.71<0.0001
  I−1.240.06−1.36, −1.13<0.0001
>14 days denervation
type IIb−0.170.01−0.19, −0.15
  IIa−0.110.01−0.14, −0.09<0.0001
  I−0.090.01−0.11, −0.06<0.0001
Gastrocnemius myofiber morphometry. Atrophy of type I, IIa, and IIb myofibers was analyzed by assessment of minimum Feret diameter at baseline (t = 0 days) and 7, 14, 30, and 72 days post-denervation. All three myofiber types showed significant atrophy within the first week after denervation, with the greatest change in magnitude observed for type IIb myofibers overall. Scale bar, 100 μm. Myofiber type-dependent atrophy during acute and chronic denervation.

RNA quality control

RNA integrity was analyzed using an Agilent 2100 Bioanalyzer (Fig. 3). The mean RNA Integrity Number (RIN) for RNA isolated from denervated and contralateral intact gastrocnemii was 7.8 ± 0.3 and 8.3 ± 0.1 (mean ± SEM), respectively, with no significant difference in RIN by denervation status.
Fig. 3

RNA integrity of samples. Following denervation for the designated durations, denervated and contralateral intact gastrocnemii were harvested and homogenized directly in TRIzol, and total RNA was column-purified. RNA samples were reverse-transcribed to cDNA and sequenced on an Illumina platform. Representative RIN tracings from one biological replicate of the cohort, showing total RNA isolated from intact gastrocnemii (a) and paired contralateral denervated gastrocnemii (b). RNA isolated from denervated and intact muscle showed similar quality (c).

RNA integrity of samples. Following denervation for the designated durations, denervated and contralateral intact gastrocnemii were harvested and homogenized directly in TRIzol, and total RNA was column-purified. RNA samples were reverse-transcribed to cDNA and sequenced on an Illumina platform. Representative RIN tracings from one biological replicate of the cohort, showing total RNA isolated from intact gastrocnemii (a) and paired contralateral denervated gastrocnemii (b). RNA isolated from denervated and intact muscle showed similar quality (c).

Read quality and base-calling accuracy

Read quality was high with Phred quality score >70 for the majority of the cycles, and lower quartile base qualities were generally high (Fig. 4). No reads or samples necessitated exclusion based on read quality. The nucleotide composition patterns (proportions of A/C/G/T) of all samples were as expected, with nearly uniform proportions of each nucleotide across sequencing cycles (with the exception of a non-random pattern of nucleotide proportions in the first 13 sequencing cycles as a result of random hexamer priming) (Fig. 5). No read trimming or filtering was required because the quality distribution and variance appeared normal across all reads and samples.
Fig. 4

Read quality. Representative distribution of Phred quality scores at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (a) and denervated (b) muscle. The boxes indicate the mean, median, and lower and upper quartile.

Fig. 5

Alignment quality. Representative distribution of A (red), C (yellow), G (green), and T (blue) at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (a) and denervated (b) muscle.

Read quality. Representative distribution of Phred quality scores at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (a) and denervated (b) muscle. The boxes indicate the mean, median, and lower and upper quartile. Alignment quality. Representative distribution of A (red), C (yellow), G (green), and T (blue) at each nucleotide, shown for the paired reads of one biological replicate for contralateral intact (a) and denervated (b) muscle.

Alignment quality

A summary of alignment statistics for all samples is provided in Tables 2–9. Similar sequencing depths and mapping rates were observed for the denervated and contralateral intact skeletal muscle samples.
Table 2

Overall summary of alignments.

CTLDN P (DN vs. CTL)*
Mean (SD),rangeMean (SD),range
Number of input reads

5.71 × 107 (8.50 × 106)

3.91 × 107–7.75 × 107

5.90 × 107 (1.15 × 107)

4.15 × 107–9.10 × 107

0.49
Average input read length138138
Number of uniquely mapped reads

4.6 × 107 (7.29 × 106)

3.17 × 107–5.88 × 107

4.89 × 107 (8.40 × 106)

3.57 × 107–6.73 × 107

0.17
Uniquely mapped reads (%)

80.47 (3.75)

73.85–85.92

83.29 (3.99)

72.3–88.62

0.009
Average mapped length

137.39 (0.42)

136.10–137.71

137.45 (0.41)

135.93–137.71

0.58
Number of splices: Total

1.62 × 107 (4.93 × 106)

5.67 × 106–2.45 × 107

1.72 × 107 (3.35 × 106)

1.00 × 107–2.38 × 107

0.37
Number of splices: Annotated (sjdb)

1.60 × 107 (4.91 × 106)

5.51 × 106–2.43 × 107

1.70 × 107 (3.33 × 106)

9.86 × 106–2.35 × 107

0.38
Number of splices: GT/AG

1.61 × 107 (4.90 × 106)

5.59 × 106–2.44 × 107

1.71 × 107 (3.33 × 106)

9.92 × 106–2.36 × 107

0.38
Number of splices: GC/AG

9.38 × 104 (2.83 × 104)

3.37 × 104–1.42 × 105

1.09 × 105 (13.37 × 104)

7.05 × 104–1.52 × 105

0.03
Number of splices: AT/AC

7.31 × 103 (2.18 × 103)

2.46 × 103–1.13 × 104

9.38 × 103 (1.95 × 103)

5.41 × 103–1.49 × 104

0.0004
Number of splices: Non-canonical

2.79 × 104 (8.77 × 103)

1.44 × 104–4.91 × 104

2.77 × 104 (8.62 × 103)

1.76 × 104–5.24 × 104

0.92
Mismatch rate per base (%)

0.28 (0.14)

0.15–0.66

0.25 (0.12)

0.15–0.68

0.32
Deletion rate per base (%)

0.002 (0.004)

0–0.01

0.001 (0.004)

0–0.01

0.49
Deletion average length

1.68 (0.32)

1.35–2.66

1.72 (0.29)

1.41–2.78

0.65
Insertion rate per base (%)

0.005 (0.008)

0–0.03

0.003 (0.007)

0–0.03

0.38
Multi-Mapping Reads:
Number of reads mapped to multiple loci

7.09 × 106 (1.34 × 106)

4.89 × 106–1.03 × 107

6.32 × 106 (2.01 × 106)

3.27 × 106–1.29 × 107

0.10
% of reads mapped to multiple loci

12.46 (1.65)

9.61–15.87

10.64 (2.15)

7.26–16.89

0.0008
Number of reads mapped to too many loci

6.16 × 105 (4.96 × 105)

1.31 × 105–1.98 × 106

4.85 × 105 (3.25 × 105)

1.45 × 105–1.66 × 106

0.25
Unmapped Reads:
% of reads unmapped: too many mismatches00
% of reads unmapped: too short

5.32 (2.21)

2.99–11.82

4.71 (2.29)

2.63–13.22

0.32

*Welch’s t-test.

Table 9

Day 90 post-denervation alignments.

CTL-90-1CTL-90-2CTL-90-3CTL-90-4DN-90-1DN-90-2DN-90-3DN-90-4
Number of input reads60,873,62947,878,30964,409,58964,474,03067,574,02841,457,41756,366,23164,290,975
Average input read length138138138138138138138138
Number of uniquely mapped reads48,591,92136,558,40654,742,09152,310,64855,842,21535,688,42749,296,56656,228,095
Uniquely mapped reads (%)79.8276.3684.9981.1382.6486.0887.4687.46
Average mapped length137.54137.33137.65137.54137.46137.62137.69137.56
Number of splices: Total17,976,0869,096,03119,807,12923,581,45314,738,62410,009,83616,531,73517,148,016
Number of splices: Annotated (sjdb)17,769,2058,892,79419,598,02323,349,41514,498,4309,862,71616,325,79216,910,940
Number of splices: GT/AG17,834,6849,003,29519,661,02223,405,84014,592,6389,915,22216,382,46416,990,053
Number of splices: GC/AG108,12648,499114,242134,946101,00570,463117,425118,687
Number of splices: AT/AC8,7613,7818,57410,4327,9685,4109,2479,501
Number of splices: Non-canonical24,51540,45623,29130,23537,01318,74122,59929,775
Mismatch rate per base (%)0.200.410.190.190.250.210.170.22
Deletion rate per base0.000.010.000.000.010.000.000.00
Deletion average length1.751.371.521.961.611.551.671.88
Insertion rate per base0.010.000.000.010.010.000.000.00
Multi-Mapping Reads:
Number of reads mapped to multiple loci7,924,8887,093,3136,681,3038,439,4576,752,7693,853,4305,037,8285,238,591
% of reads mapped to multiple loci13.0214.8210.3713.099.999.298.948.15
Number of reads mapped to too many loci469,2501,545,968447,456176,878855,527419,702172,340444,439
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short5.924.163.345.345.232.772.883.10
Overall summary of alignments. 5.71 × 107 (8.50 × 106) 3.91 × 107–7.75 × 107 5.90 × 107 (1.15 × 107) 4.15 × 107–9.10 × 107 4.6 × 107 (7.29 × 106) 3.17 × 107–5.88 × 107 4.89 × 107 (8.40 × 106) 3.57 × 107–6.73 × 107 80.47 (3.75) 73.85–85.92 83.29 (3.99) 72.3–88.62 137.39 (0.42) 136.10–137.71 137.45 (0.41) 135.93–137.71 1.62 × 107 (4.93 × 106) 5.67 × 106–2.45 × 107 1.72 × 107 (3.35 × 106) 1.00 × 107–2.38 × 107 1.60 × 107 (4.91 × 106) 5.51 × 106–2.43 × 107 1.70 × 107 (3.33 × 106) 9.86 × 106–2.35 × 107 1.61 × 107 (4.90 × 106) 5.59 × 106–2.44 × 107 1.71 × 107 (3.33 × 106) 9.92 × 106–2.36 × 107 9.38 × 104 (2.83 × 104) 3.37 × 104–1.42 × 105 1.09 × 105 (13.37 × 104) 7.05 × 104–1.52 × 105 7.31 × 103 (2.18 × 103) 2.46 × 103–1.13 × 104 9.38 × 103 (1.95 × 103) 5.41 × 103–1.49 × 104 2.79 × 104 (8.77 × 103) 1.44 × 104–4.91 × 104 2.77 × 104 (8.62 × 103) 1.76 × 104–5.24 × 104 0.28 (0.14) 0.15–0.66 0.25 (0.12) 0.15–0.68 0.002 (0.004) 0–0.01 0.001 (0.004) 0–0.01 1.68 (0.32) 1.35–2.66 1.72 (0.29) 1.41–2.78 0.005 (0.008) 0–0.03 0.003 (0.007) 0–0.03 7.09 × 106 (1.34 × 106) 4.89 × 106–1.03 × 107 6.32 × 106 (2.01 × 106) 3.27 × 106–1.29 × 107 12.46 (1.65) 9.61–15.87 10.64 (2.15) 7.26–16.89 6.16 × 105 (4.96 × 105) 1.31 × 105–1.98 × 106 4.85 × 105 (3.25 × 105) 1.45 × 105–1.66 × 106 5.32 (2.21) 2.99–11.82 4.71 (2.29) 2.63–13.22 *Welch’s t-test. Day 0 (baseline) alignments. Day 1 post-denervation alignments. Day 3 post-denervation alignments. Day 7 post-denervation alignments. Day 14 post-denervation alignments. Day 30 post-denervation alignments. Day 90 post-denervation alignments.

Counts per gene

The distribution of normalized gene accounts appears similar among all samples in the dataset (Fig. 6).
Fig. 6

Summary of read counts. Density plot showing relative read count distributions for all samples.

Summary of read counts. Density plot showing relative read count distributions for all samples.

Unsupervised clustering analysis of longitudinally denervated samples

Multidimensional scaling using expression levels of all genes demonstrated temporal clustering based on denervation status, with replicates within each denervation timepoint clustering closer to each other than to other denervation timepoints (Fig. 7).
Fig. 7

Quality of replicates. Multi-dimensional scaling analysis (a) and cluster dendrogram (b) of transcriptional profiles during neurogenic atrophy shows temporal clustering by denervation status.

Quality of replicates. Multi-dimensional scaling analysis (a) and cluster dendrogram (b) of transcriptional profiles during neurogenic atrophy shows temporal clustering by denervation status.

Time-dependent comparison of denervated and contralateral intact skeletal muscle transcriptomes

Normalized gene counts from denervated and contralateral intact skeletal muscle at each timepoint are compared in scatter plots (Fig. 8).
Fig. 8

Gene expression visualization. Scatterplots showing the log2 transform of normalized counts.

Gene expression visualization. Scatterplots showing the log2 transform of normalized counts.

Differential expression analysis

MA-plots showing the log-fold change (M-values, the log of the ratio of counts for each gene across the two samples being compared) against the normalized log-average (A-values, the average counts for each gene across the two samples being compared) indicate substantial differences in gene expression in skeletal muscle during acute and chronic neurogenic atrophy (Fig. 9a–g). Volcano plots indicate minimal differences in gene expression at baseline (intact muscle) (Fig. 9h), but demonstrate that thousands of genes are significantly differentially expressed (FDR < 0.1) within the first day after denervation (Fig. 9i) and beyond (Fig. 9j–n). A summary of the number of differentially expressed genes at each timepoint is shown in Fig. 9o.
Fig. 9

Differential expression analysis. MA-plots comparing the log2 fold change of gene expression for denervated vs. contralateral intact skeletal muscle at each timepoint plotted against the normalized average of the counts (a–g). Volcano plots showing the -log10 FDR for difference in expression between denervated and contralateral intact skeletal muscle for each gene detected, plotted against the log2 fold-change (h–n). Genes with FDR < 0.1 are depicted in red. The total number of significantly differentially expressed genes (FDR < 0.1) at each timepoint is summarized in panel (o).

Differential expression analysis. MA-plots comparing the log2 fold change of gene expression for denervated vs. contralateral intact skeletal muscle at each timepoint plotted against the normalized average of the counts (a–g). Volcano plots showing the -log10 FDR for difference in expression between denervated and contralateral intact skeletal muscle for each gene detected, plotted against the log2 fold-change (h–n). Genes with FDR < 0.1 are depicted in red. The total number of significantly differentially expressed genes (FDR < 0.1) at each timepoint is summarized in panel (o).

Usage Notes

The RNA-Seq dataset presented in this study provides a detailed view of the acute and chronic gene expression changes that occur in denervated, atrophying skeletal muscle. These data may provide insight into the early events associated with acute loss of neuronal input that trigger rapid atrophy, as well as the gene expression changes in chronically denervated and severely atrophied skeletal muscle associated with impaired capacity for reinnervation. Defining these changes may afford opportunities to limit the rate and severity of skeletal muscle atrophy, and to enhance functional reinnervation. Supplementary Table 1
Measurement(s)skeletal muscle atrophy • gene expression
Technology Type(s)RNA sequencing
Factor Type(s)denervation status • denervation duration
Sample Characteristic - OrganismMus musculus
Table 3

Day 0 (baseline) alignments.

CTL-0-1CTL-0-2CTL-0-3CTL-0-4DN-0-1DN-0-2DN-0-3DN-0-4
Number of input reads55,742,41555,520,60955,035,74763,030,55561,655,19346,879,30268,278,35390,993,687
Average input read length138138138138138138138138
Number of uniquely mapped reads44,288,33042,269,60646,785,17352,763,03949,365,74536,068,97356,573,59365,791,821
Uniquely mapped reads (%)79.4576.1385.0183.7180.0776.9482.8672.30
Average mapped length137.29136.1137.64137.57137.2137.61137.61135.93
Number of splices: Total13,449,62811,337,80017,752,38019,213,53613,937,30315,460,97723,318,21422,103,629
Number of splices: Annotated (sjdb)13,279,96411,188,95217,562,68718,981,11113,722,59515,257,24323,063,15221,856,608
Number of splices: GT/AG13,338,07511,231,53217,622,78019,059,81013,811,90515,337,67523,148,26821,924,998
Number of splices: GC/AG79,14170,961100,965116,59783,25493,607131,002128,493
Number of splices: AT/AC6,6135,4707,8148,7797,2047,56910,12710,049
Number of splices: Non-canonical25,79929,83720,82128,35039,94022,12628,81740,089
Mismatch rate per base (%)0.320.640.190.210.310.220.190.68
Deletion rate per base (%)0.000.010.000.000.000.000.000.01
Deletion average length1.842.661.551.591.651.461.562.78
Insertion rate per base (%)0.010.030.000.000.010.000.000.03
Multi-Mapping Reads:
Number of reads mapped to multiple loci7,297,2466,213,0495,623,2936,892,9067,920,7307,915,6207,813,51512,905,331
% of reads mapped to multiple loci13.0911.1910.2210.9412.8516.8911.4414.18
Number of reads mapped to too many loci582,753255,211341,804568,680987,746539,784463,089172,576
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short5.6311.823.693.954.634.624.6613.22
Table 4

Day 1 post-denervation alignments.

CTL-1-1CTL-1-2CTL-1-3CTL-1-4DN-1-1DN-1-2DN-1-3DN-1-4
Number of input reads61,636,87258,072,07755,973,09671,794,34458,034,87648,989,93173,886,62274,271,951
Average input read length138138138138138138138138
Number of uniquely mapped reads45,746,32547,654,85648,094,86658,843,89048,750,12039,908,06162,480,23556,047,037
Uniquely mapped reads (%)74.2282.0685.9281.9684.0081.4684.5675.46
Average mapped length137.34137.47137.57137.6137.62137.59137.57136.25
Number of splices: Total9,070,91116,321,20018,716,28724,549,73817,994,49013,613,41423,080,27317,817,564
Number of splices: Annotated (sjdb)8,836,38416,122,23318,519,78324,297,36117,785,15813,408,13522,808,43117,582,261
Number of splices: GT/AG8,966,85116,190,88718,583,61424,365,74317,858,25513,494,72222,900,17617,663,375
Number of splices: GC/AG50,71396,907103,605141,926103,87783,585134,880108,178
Number of splices: AT/AC4,2557,4668,26711,2768,3276,87811,0308,758
Number of splices: Non-canonical49,09225,94020,80130,79324,03128,17934,18737,253
Mismatch rate per base (%)0.400.260.230.170.190.250.210.63
Deletion rate per base0.010.000.000.000.000.000.000.01
Deletion average length1.371.631.841.711.491.451.662.4
Insertion rate per base0.000.010.000.010.000.000.000.02
Multi-Mapping Reads:
Number of reads mapped to multiple loci9,782,7056,777,4465,377,7728,642,6056,176,5215,844,0147,396,7199,668,787
% of reads mapped to multiple loci15.8711.679.6112.0410.6411.9310.0113.02
Number of reads mapped to too many loci1,984,894619,936341,393194,108530,916812,052596,417413,918
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short5.124.553.445.553.794.174.1310.71
Table 5

Day 3 post-denervation alignments.

CTL-3-1CTL-3-2CTL-3-3CTL-3-4DN-3-1DN-3-2DN-3-3DN-3-4
Number of input reads43,601,76739,051,34660,982,53277,529,16761,614,60948,980,17077,233,03249,001,916
Average input read length138138138138138138138138
Number of uniquely mapped reads32,795,16931,708,28051,656,26458,276,50548,300,39840,533,61567,261,85340,543,472
Uniquely mapped reads (%)75.2281.2084.7175.1778.3982.7687.0982.74
Average mapped length137.18137.54137.63136.29137.27137.61137.58137.7
Number of splices: Total7,641,73214,023,14919,917,67620,730,82412,188,89315,689,66023,843,24218,125,528
Number of splices: Annotated (sjdb)7,481,95613,875,66219,704,84420,503,65911,912,73015,485,35523,536,88817,920,443
Number of splices: GT/AG7,559,26913,909,11019,774,05920,569,91412,051,29015,551,27223,642,78717,982,044
Number of splices: GC/AG44,92289,610110,632117,09276,969104,920151,795114,053
Number of splices: AT/AC3,7516,8278,9199,8648,21710,33314,85911,510
Number of splices: Non-canonical33,79017,60224,06633,95452,41723,13533,80117,921
Mismatch rate per base (%)0.370.180.180.570.350.200.210.15
Deletion rate per base0.000.000.000.010.010.000.000.00
Deletion average length1.451.931.542.641.411.761.741.65
Insertion rate per base0.000.010.000.020.000.000.000.00
Multi-Mapping Reads:
Number of reads mapped to multiple loci5,971,1344,893,8126,531,89110,323,3338,224,6405,219,4486,412,4476,047,917
% of reads mapped to multiple loci13.6912.5310.7113.3213.3510.668.3012.34
Number of reads mapped to too many loci1,070,563150,149453,705168,9491,656,313391,356516,587143,641
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short7.355.563.2811.174.335.333.354.41
Table 6

Day 7 post-denervation alignments.

CTL-7-1CTL-7-2CTL-7-3CTL-7-4DN-7-1DN-7-2DN-7-3DN-7-4
Number of input reads60,590,61056,143,55852,019,27551,496,20159,955,86252,135,01456,347,86049,238,405
Average input read length138138138138138138138138
Number of uniquely mapped reads44,746,34945,413,96543,059,55841,428,22848,787,07744,968,95948,225,33341,382,042
Uniquely mapped reads (%)73.8580.8982.7880.4581.3786.2585.5984.04
Average mapped length137.59137.52137.55137.52137.54137.62137.62137.71
Number of splices: Total14,703,98016,917,30615,994,82419,253,85618,108,36717,195,99519,296,26617,537,132
Number of splices: Annotated (sjdb)14,509,68816,698,11715,827,80619,075,52117,848,55516,979,72619,078,13917,331,026
Number of splices: GT/AG14,581,73616,782,95815,879,43119,119,49317,951,60617,055,43619,144,65617,402,247
Number of splices: GC/AG87,62994,17590,057109,413113,654107,871121,143107,129
Number of splices: AT/AC6,9827,2596,7138,33511,44410,33110,95110,114
Number of splices: Non-canonical27,63332,91418,62316,61531,66322,35719,51617,642
Mismatch rate per base (%)0.230.250.240.200.210.190.230.16
Deletion rate per base0.000.000.000.000.000.000.000.00
Deletion average length1.461.61.551.661.51.681.611.58
Insertion rate per base0.000.000.000.010.000.000.000.00
Multi-Mapping Reads:
Number of reads mapped to multiple loci9,428,2466,672,2055,740,0426,966,7637,352,3274,543,2025,722,8485,194,049
% of reads mapped to multiple loci15.5611.8811.0313.5312.268.7110.1610.55
Number of reads mapped to too many loci819,014789,365391,842166,663716,324332,671233,636243,367
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short8.415.234.835.534.513.913.514.58
Table 7

Day 14 post-denervation alignments.

CTL-14-1CTL-14-2CTL-14-3CTL-14-4DN-14-1DN-14-2DN-14-3DN-14-4
Number of input reads49,441,64669,876,92457,832,49747,973,29955,891,42944,966,50959,715,01654,942,368
Average input read length138138138138138138138138
Number of uniquely mapped reads36,913,92657,899,59548,950,62338,979,82646,402,58539,850,07451,086,87647,212,433
Uniquely mapped reads (%)74.6682.8684.6481.2583.0288.6285.5585.93
Average mapped length136.42137.57137.64137.71137.43137.6137.26137.64
Number of splices: Total5,674,22821,316,99117,945,54818,202,91514,603,77813,578,93817,163,85119,981,473
Number of splices: Annotated (sjdb)5,507,05821,070,68217,756,78218,029,15814,378,27613,404,59816,946,76119,745,905
Number of splices: GT/AG5,594,71721,157,48017,811,04118,071,86114,465,58213,467,59117,016,21819,822,262
Number of splices: GC/AG33,738117,529105,892108,30997,38986,275114,337126,876
Number of splices: AT/AC2,4608,9337,6818,3768,4157,2299,54011,690
Number of splices: Non-canonical43,31333,04920,93414,36932,39217,84323,75620,645
Mismatch rate per base (%)0.660.220.190.150.230.210.300.17
Deletion rate per base0.010.000.000.000.000.000.000.00
Deletion average length1.961.531.491.541.61.731.771.81
Insertion rate per base0.020.000.000.000.000.000.000.00
Multi-Mapping Reads:
Number of reads mapped to multiple loci6,729,8028,099,8026,448,8166,968,3575,711,9633,266,2555,086,8575,109,283
% of reads mapped to multiple loci13.6111.5911.1514.5310.227.268.529.30
Number of reads mapped to too many loci1,288,797704,083369,246131,113711,573285,356277,105152,218
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short7.923.982.993.774.722.934.974.27
Table 8

Day 30 post-denervation alignments.

CTL-30-1CTL-30-2CTL-30-3CTL-30-4DN-30-1DN-30-2DN-30-3DN-30-4
Number of input reads52,742,87846,463,40357,501,21960,468,55373,590,72748,399,32251,665,57954,577,655
Average input read length138138138138138138138138
Number of uniquely mapped reads40,308,92438,146,89648,521,24749,438,87258,520,85241,879,30345,337,49446,751,912
Uniquely mapped reads (%)76.4382.1084.3881.7679.5286.5387.7585.66
Average mapped length137.26137.46137.68137.65137.6137.5137.65137.55
Number of splices: Total9,002,16412,162,16217,453,82421,318,00519,800,20214,238,82217,245,13817,175,362
Number of splices: Annotated (sjdb)8,779,54111,999,10217,264,63421,090,38719,528,56714,056,75017,044,05916,948,110
Number of splices: GT/AG8,902,80712,063,47317,319,77021,157,40919,623,21714,122,31517,105,74517,027,539
Number of splices: GC/AG50,01369,863105,703125,956132,94788,561112,478111,959
Number of splices: AT/AC4,1295,4397,9899,58711,1336,8768,9579,017
Number of splices: Non-canonical45,21523,38720,36225,05332,90521,07017,95826,847
Mismatch rate per base (%)0.410.340.180.180.210.230.160.22
Deletion rate per base0.010.000.000.000.000.000.000.00
Deletion average length1.351.541.521.541.592.11.611.85
Insertion rate per base0.000.000.000.000.000.010.000.01
Multi-Mapping Reads:
Number of reads mapped to multiple loci7,401,2845,478,2486,190,6008,046,2938,580,9504,181,4324,632,1805,281,885
% of reads mapped to multiple loci14.0311.7910.7713.3111.668.648.979.68
Number of reads mapped to too many loci1,771,867704,627353,874396,886672,558312,239158,758369,051
Unmapped Reads:
% of reads unmapped: too many mismatches0.000.000.000.000.000.000.000.00
% of reads unmapped: too short4.843.823.703.987.273.682.633.59
  38 in total

1.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.

Authors:  Jennifer M Sacheck; Jon-Philippe K Hyatt; Anna Raffaello; R Thomas Jagoe; Roland R Roy; V Reggie Edgerton; Stewart H Lecker; Alfred L Goldberg
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

2.  Systematic review of the prognostic role of body mass index in amyotrophic lateral sclerosis.

Authors:  Pingping Ning; Baiyuan Yang; Shuangjiang Li; Xin Mu; Qiuyan Shen; Fayun Hu; Yao Tang; Xinglong Yang; Yanming Xu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-04-01       Impact factor: 4.092

Review 3.  Disuse-induced muscle wasting.

Authors:  Sue C Bodine
Journal:  Int J Biochem Cell Biol       Date:  2013-06-22       Impact factor: 5.085

Review 4.  Glucocorticoid-induced skeletal muscle atrophy.

Authors:  O Schakman; S Kalista; C Barbé; A Loumaye; J P Thissen
Journal:  Int J Biochem Cell Biol       Date:  2013-06-24       Impact factor: 5.085

5.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy.

Authors:  M D Gomes; S H Lecker; R T Jagoe; A Navon; A L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy.

Authors:  R Medina; S S Wing; A L Goldberg
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

Review 7.  Cancer Cachexia: More Than Skeletal Muscle Wasting.

Authors:  Søren Fisker Schmidt; Maria Rohm; Stephan Herzig; Mauricio Berriel Diaz
Journal:  Trends Cancer       Date:  2018-10-24

8.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

9.  Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy.

Authors:  K Furuno; M N Goodman; A L Goldberg
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

10.  Direct optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophy.

Authors:  Philippe Magown; Basavaraj Shettar; Ying Zhang; Victor F Rafuse
Journal:  Nat Commun       Date:  2015-10-13       Impact factor: 14.919

View more
  8 in total

1.  SARM1 knockout does not rescue neuromuscular phenotypes in a Charcot-Marie-Tooth disease Type 1A mouse model.

Authors:  Kathryn R Moss; Anna E Johnson; Taylor S Bopp; Andrew T Yu; Ken Perry; Tae Chung; Ahmet Höke
Journal:  J Peripher Nerv Syst       Date:  2022-02-13       Impact factor: 3.494

2.  CUL3 and COPS5 Related to the Ubiquitin-Proteasome Pathway Are Potential Genes for Muscle Atrophy in Mice.

Authors:  Qun Xu; Jinyou Li; Ji Yang; Zherong Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

3.  Changes of Gene Expression Patterns of Muscle Pathophysiology-Related Transcription Factors During Denervated Muscle Atrophy.

Authors:  Xiaoming Yang; Ming Li; Yanan Ji; Yinghao Lin; Lai Xu; Xiaosong Gu; Hualin Sun; Wei Wang; Yuntian Shen; Hua Liu; Jianwei Zhu
Journal:  Front Physiol       Date:  2022-06-24       Impact factor: 4.755

4.  High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death.

Authors:  Junko Tsuji; Travis Thomson; Elizabeth Chan; Christine K Brown; Julia Oppenheimer; Carol Bigelow; Xianjun Dong; William E Theurkauf; Zhiping Weng; Lawrence M Schwartz
Journal:  Physiol Genomics       Date:  2020-09-14       Impact factor: 3.107

5.  Transcriptome Integration Analysis at Different Embryonic Ages Reveals Key lncRNAs and mRNAs for Chicken Skeletal Muscle.

Authors:  Pengfei Wu; Kaizhi Zhou; Jin Zhang; Xuanze Ling; Xinchao Zhang; Peifeng Li; Li Zhang; Qingyu Wei; Tao Zhang; Kaizhou Xie; Genxi Zhang
Journal:  Front Vet Sci       Date:  2022-06-16

6.  Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth.

Authors:  Rossella Delle Donne; Rosa Iannucci; Laura Rinaldi; Luca Roberto; Maria A Oliva; Emanuela Senatore; Domenica Borzacchiello; Luca Lignitto; Giorgio Giurato; Francesca Rizzo; Assunta Sellitto; Francesco Chiuso; Salvatore Castaldo; Giovanni Scala; Virginia Campani; Valeria Nele; Giuseppe De Rosa; Chiara D'Ambrosio; Corrado Garbi; Andrea Scaloni; Alessandro Weisz; Concetta Ambrosino; Antonella Arcella; Antonio Feliciello
Journal:  Commun Biol       Date:  2022-08-02

7.  Adult-Onset Myopathy with Constitutive Activation of Akt following the Loss of hnRNP-U.

Authors:  Debalina Bagchi; Benjamin D Mason; Kodilichi Baldino; Bin Li; Eun-Joo Lee; Yuteng Zhang; Linh Khanh Chu; Sherif El Raheb; Indranil Sinha; Ronald L Neppl
Journal:  iScience       Date:  2020-06-29

8.  GADD45A is a protective modifier of neurogenic skeletal muscle atrophy.

Authors:  Jeffrey T Ehmsen; Riki Kawaguchi; Damlanur Kaval; Anna E Johnson; Daniel Nachun; Giovanni Coppola; Ahmet Höke
Journal:  JCI Insight       Date:  2021-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.